VistaGen Therapeutics (NASDAQ: VTGN) Featured Research Report

9 A EGIS C APITAL C ORP. Fig. 6. Subjective Units of Distress (SUDS) scale Source: Oxford Clinical Psychology VistaGen Therapeutics, Inc. October 8, 2020